EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of Plasmodium berghei liver stages

Grace Kennedy, Rachel M West, Kristin Poti, Bryce Bobb, Matthew M Ippolito, Mark A Marzinke iD, Nikola Kaludov, David J Sullivan iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00215-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Grace Kennedy und 7 weiteren Autor:innen. Beteiligte Einrichtung: W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Plasmodium berghei, Malaria, Liver, Antimalarials. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maryland TEDCO, NCATS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cethromycin combines a quinoline nucleus and a macrolide for broad-spectrum antibacterial and antiprotozoan activity. Here, we characterized the murine pharmacokinetics and Plasmodium berghei lifecycle stage pharmacodynamics for the cethromycin base. Liver pharmacokinetic studies in mice show peak mM drug concentrations in the liver with 20 hour sustained levels above 10 μM. Peak concentrations in the liver were double the lung and about 440 times that of plasma. Immunofluorescence imaging of in vitro cethromycin-treated infected hepatocytes shows complete ablation of the apicoplast. We observed complete cure of P. berghei liver-stage infection by a single oral dose of 60 mg/kg in mice, which is equivalent to the 5 mg/kg human dose of 300 mg a day used in bacterial pneumonia studies. Cethromycin at 60 mg/kg daily for 7 days was curative in the high parasitemic P. berghei mouse model. Both mosquito membrane feeding of Plasmodium falciparum gametocytes incubated with 20 μM cethromycin and oral dosing in mice demonstrated no decrease in oocyst numbers. Cethromycin has been evaluated for efficacy against bacterial pneumonia in more than 5,000 patients with good safety profiles. Cethromycin has potential for rapid clinical development for casual malaria prophylaxis and possibly radical cure of dormant liver Plasmodium vivax .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium bergheiMalariaLiverAntimalarialsAnimalsMiceFemaleHepatocytesHumansPlasmodium falciparum

Stichwörter der Autor:innen

antimalarial agentsblood stagecethromycinchemotherapyliver stage

Substanzen

Antimalarials

Autor:innen und Institutionen

  • W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Clinical Pharmacology, Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • AliQuantumRx Inc, Baltimore, Maryland, USA.

ORCID-Profile: Mark A Marzinke, David J Sullivan

Förderung

  • Maryland TEDCO
  • NCATS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Kennedy, G., West, R. M., Poti, K., Bobb, B., Ippolito, M. M., Marzinke, M. A., Kaludov, N., & Sullivan, D. J. (2025). Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of Plasmodium berghei liver stages. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00215-25

Vancouver

Kennedy G, West RM, Poti K, Bobb B, Ippolito MM, Marzinke MA, et al. Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of Plasmodium berghei liver stages. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00215-25

BibTeX
@article{Kennedy2025,
  author = {Kennedy, Grace and West, Rachel M and Poti, Kristin and Bobb, Bryce and Ippolito, Matthew M and Marzinke, Mark A and Kaludov, Nikola and Sullivan, David J},
  title = {Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of Plasmodium berghei liver stages},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00215-25}
}
Kostenlos starten →